Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1582, doi. 10.3390/cancers16081582
- By:
- Publication type:
- Article
Works by Zheng, Shunzhen
Results: 4
1
2
Mesencephalic Astrocyte-Derived Neurotrophic Factor, a Prognostic Factor of Cholangiocarcinoma, Affects Sorafenib Sensitivity of Cholangiocarcinoma Cells by Deteriorating ER Stress.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 9169, doi. 10.2147/OTT.S245575
- By:
- Publication type:
- Article
3
Characterization of 9-Nitrocamptothecin Liposomes: Anticancer Properties and Mechanisms on Hepatocellular Carcinoma In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021064
- By:
- Publication type:
- Article
4
Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/1936385
- By:
- Publication type:
- Article